Global Health (GLH.AX) Stock Price

Global Health Price

ASX·CLOSED
0.06AUD+0.00 (+0.00 %)
Market closed

Over the last 19 years Global Health grew revenue by 2.7% annually, reaching 8.70 M AUD. Earnings per share have grown at 5.0% per year over the last 4 years. For Global Health, the net margin of -10.0% is down versus -6.9% a few years ago. At today's price the dividend yield works out to roughly 15.38%. The payout ratio is around 20% of earnings. The stock trades about 23% above its 52-week low.

Global Health stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Global Health over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Global Health stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Global Health's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Global Health Stock Price History
DateGlobal Health Price
7/13/20260.06 AUD
7/10/20260.06 AUD
7/9/20260.06 AUD
7/8/20260.06 AUD
7/7/20260.06 AUD
7/6/20260.06 AUD
7/3/20260.06 AUD
7/2/20260.06 AUD
7/1/20260.06 AUD
6/30/20260.06 AUD
6/29/20260.06 AUD
6/26/20260.06 AUD
6/25/20260.05 AUD
6/24/20260.05 AUD
6/23/20260.05 AUD
6/22/20260.05 AUD
6/19/20260.05 AUD
6/18/20260.05 AUD
6/17/20260.05 AUD
6/16/20260.05 AUD
6/15/20260.05 AUD
6/12/20260.05 AUD
6/11/20260.06 AUD
6/10/20260.06 AUD
6/9/20260.06 AUD
6/5/20260.06 AUD
6/4/20260.06 AUD
6/3/20260.06 AUD
6/2/20260.06 AUD
6/1/20260.06 AUD
5/29/20260.06 AUD
5/28/20260.06 AUD
5/27/20260.06 AUD
5/26/20260.06 AUD
5/25/20260.06 AUD
5/22/20260.06 AUD
5/21/20260.06 AUD
5/20/20260.06 AUD
5/19/20260.06 AUD
5/18/20260.06 AUD
5/15/20260.06 AUD
5/14/20260.06 AUD
5/13/20260.06 AUD
5/12/20260.06 AUD
5/11/20260.06 AUD
5/8/20260.06 AUD
5/7/20260.06 AUD
5/6/20260.06 AUD
5/5/20260.06 AUD
5/4/20260.06 AUD
5/1/20260.06 AUD
4/30/20260.07 AUD
4/29/20260.07 AUD
4/28/20260.07 AUD
4/27/20260.07 AUD
4/24/20260.07 AUD
4/23/20260.07 AUD
4/22/20260.07 AUD
4/21/20260.08 AUD
4/20/20260.08 AUD
4/17/20260.07 AUD
4/16/20260.07 AUD
4/15/20260.07 AUD
4/14/20260.07 AUD
4/13/20260.07 AUD
4/10/20260.07 AUD
4/9/20260.07 AUD
4/8/20260.07 AUD
4/7/20260.07 AUD
4/2/20260.07 AUD
4/1/20260.07 AUD
3/31/20260.07 AUD
3/30/20260.07 AUD
3/27/20260.07 AUD
3/26/20260.07 AUD
3/25/20260.07 AUD
3/24/20260.07 AUD
3/23/20260.07 AUD
3/20/20260.07 AUD
3/19/20260.07 AUD
3/18/20260.07 AUD
3/17/20260.07 AUD
3/16/20260.07 AUD
3/13/20260.07 AUD
3/12/20260.07 AUD
3/11/20260.07 AUD
3/10/20260.07 AUD
3/9/20260.07 AUD
3/6/20260.07 AUD
3/5/20260.07 AUD
3/4/20260.07 AUD
3/3/20260.07 AUD
3/2/20260.07 AUD
2/27/20260.07 AUD
2/26/20260.07 AUD
2/25/20260.07 AUD
2/24/20260.07 AUD
2/23/20260.07 AUD
2/20/20260.07 AUD
2/19/20260.07 AUD
2/18/20260.07 AUD
2/17/20260.07 AUD
2/16/20260.07 AUD
2/13/20260.07 AUD
2/12/20260.07 AUD
2/11/20260.07 AUD
2/10/20260.07 AUD
2/9/20260.07 AUD
2/6/20260.07 AUD
2/5/20260.07 AUD
2/4/20260.08 AUD
2/3/20260.08 AUD
2/2/20260.08 AUD
1/30/20260.08 AUD
1/29/20260.08 AUD
1/28/20260.08 AUD
1/27/20260.08 AUD
1/23/20260.08 AUD
1/22/20260.08 AUD
1/21/20260.08 AUD
1/20/20260.08 AUD
1/19/20260.08 AUD
1/16/20260.08 AUD
1/15/20260.08 AUD
1/14/20260.07 AUD
1/13/20260.07 AUD
1/12/20260.09 AUD
1/9/20260.09 AUD
1/8/20260.09 AUD
1/7/20260.09 AUD
1/6/20260.09 AUD
1/5/20260.09 AUD
1/2/20260.09 AUD
12/31/20250.09 AUD
12/30/20250.09 AUD
12/29/20250.08 AUD
12/24/20250.08 AUD
12/23/20250.08 AUD
12/22/20250.08 AUD
12/19/20250.09 AUD
12/18/20250.09 AUD
12/17/20250.09 AUD
12/16/20250.09 AUD
12/15/20250.09 AUD
12/12/20250.09 AUD
12/11/20250.09 AUD
12/10/20250.09 AUD
12/9/20250.09 AUD
12/8/20250.09 AUD
12/5/20250.09 AUD
12/4/20250.09 AUD
12/3/20250.09 AUD
12/2/20250.09 AUD
12/1/20250.09 AUD
11/28/20250.09 AUD
11/27/20250.10 AUD
11/26/20250.10 AUD
11/25/20250.10 AUD
11/24/20250.10 AUD
11/21/20250.10 AUD
11/20/20250.09 AUD
11/19/20250.09 AUD
11/18/20250.09 AUD
11/17/20250.09 AUD
11/14/20250.10 AUD
11/13/20250.10 AUD
11/12/20250.10 AUD
11/11/20250.09 AUD
11/10/20250.09 AUD
11/7/20250.10 AUD
11/6/20250.10 AUD
11/5/20250.10 AUD
11/4/20250.10 AUD
11/3/20250.10 AUD
10/31/20250.10 AUD
10/30/20250.10 AUD
10/29/20250.10 AUD
10/28/20250.10 AUD
10/27/20250.10 AUD
10/24/20250.10 AUD
10/23/20250.10 AUD
10/22/20250.10 AUD
10/21/20250.10 AUD
10/20/20250.10 AUD
10/17/20250.10 AUD
10/16/20250.10 AUD
10/15/20250.10 AUD
10/14/20250.10 AUD
10/13/20250.10 AUD
10/10/20250.10 AUD
10/9/20250.10 AUD
10/8/20250.10 AUD
10/7/20250.10 AUD
10/6/20250.10 AUD
10/3/20250.10 AUD
10/2/20250.10 AUD
10/1/20250.10 AUD
9/30/20250.10 AUD
9/29/20250.10 AUD
9/26/20250.10 AUD
9/25/20250.12 AUD
9/24/20250.12 AUD
9/23/20250.12 AUD
9/22/20250.12 AUD
9/19/20250.13 AUD
9/18/20250.13 AUD
9/17/20250.13 AUD
9/16/20250.13 AUD
9/15/20250.14 AUD
9/12/20250.14 AUD
9/11/20250.14 AUD
9/10/20250.13 AUD
9/9/20250.13 AUD
9/8/20250.12 AUD
9/5/20250.11 AUD
9/4/20250.11 AUD
9/3/20250.10 AUD
9/2/20250.10 AUD
9/1/20250.09 AUD
8/29/20250.09 AUD
8/28/20250.09 AUD
8/27/20250.11 AUD
8/26/20250.11 AUD
8/25/20250.11 AUD
8/22/20250.11 AUD
8/21/20250.11 AUD
8/20/20250.11 AUD
8/19/20250.10 AUD
8/18/20250.10 AUD
8/15/20250.09 AUD
8/14/20250.10 AUD
8/13/20250.09 AUD
8/12/20250.09 AUD
8/11/20250.09 AUD
8/8/20250.08 AUD
8/7/20250.08 AUD
8/6/20250.08 AUD
8/5/20250.08 AUD
8/4/20250.08 AUD
8/1/20250.08 AUD
7/31/20250.08 AUD
7/30/20250.08 AUD
7/29/20250.08 AUD
7/28/20250.08 AUD
7/25/20250.07 AUD
7/24/20250.07 AUD
7/23/20250.08 AUD
7/22/20250.07 AUD
7/21/20250.07 AUD
7/18/20250.08 AUD
7/17/20250.08 AUD
Access this data via the Eulerpool API
Get Free API Key

Global Health Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2018
5.17 M AUD
-1.13 M AUD
-1.86 M AUD
Jan 1, 2019
5.52 M AUD
-833,400.00 AUD
-1.30 M AUD
Jan 1, 2020
6.26 M AUD
-131,800.00 AUD
-60,100.00 AUD
Jan 1, 2021
7.03 M AUD
-8,300.00 AUD
-488,000.00 AUD
Jan 1, 2022
6.54 M AUD
-1.98 M AUD
-2.05 M AUD
Jan 1, 2023
7.82 M AUD
-3.73 M AUD
-8.05 M AUD
Jan 1, 2024
8.67 M AUD
-1.22 M AUD
-1.31 M AUD
Jan 1, 2025
8.70 M AUD
-769,300.00 AUD
-866,600.00 AUD

Global Health Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jul 16, 2026, 5:25 AM
 
REVENUEM AUD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM AUD
NET INCOMEM AUD
NET INCOME GROWTH%
DIV.AUD
SHARESM
2010201120122013201420152016201720182019202020212022202320242025
5.005.004.004.005.004.005.0010.005.005.006.007.006.007.008.008.00
-16.67–-20.00–25.00-20.0025.00100.00-50.00–20.0016.67-14.2916.6714.29–
80.00100.0075.00100.00100.00100.0080.0090.0060.0060.0066.6771.4366.6785.7187.5075.00
4.005.003.004.005.004.004.009.003.003.004.005.004.006.007.006.00
–––1.001.001.00–1.00-1.00-1.00––-2.00-8.00-1.00–
––––––––-200.00––––300.00-87.50–
––––––0.01–––––––––
19.3823.6023.6029.1034.8534.9235.1237.6635.7035.8139.0442.3656.0057.5258.0558.21
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Global Health generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Global Health retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Global Health's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Global Health has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Global Health's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Global Health stock margins

The Global Health margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Global Health. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Global Health.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2018
72.69 %
-21.86 %
-35.95 %
Jan 1, 2019
71.72 %
-15.08 %
-23.47 %
Jan 1, 2020
79.92 %
-2.11 %
-0.96 %
Jan 1, 2021
76.47 %
-0.12 %
-6.94 %
Jan 1, 2022
74.28 %
-30.23 %
-31.35 %
Jan 1, 2023
79.88 %
-47.70 %
-103.03 %
Jan 1, 2024
81.18 %
-14.04 %
-15.14 %
Jan 1, 2025
76.92 %
-8.84 %
-9.96 %

Global Health Stock Revenue, EBIT, Earnings per Share

The Global Health earnings per share therefore indicates how much revenue Global Health has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2018
0.14 AUD
-0.03 AUD
-0.05 AUD
Jan 1, 2019
0.15 AUD
-0.02 AUD
-0.04 AUD
Jan 1, 2020
0.16 AUD
-0.00 AUD
-0.00 AUD
Jan 1, 2021
0.17 AUD
-0.00 AUD
-0.01 AUD
Jan 1, 2022
0.12 AUD
-0.04 AUD
-0.04 AUD
Jan 1, 2023
0.14 AUD
-0.06 AUD
-0.14 AUD
Jan 1, 2024
0.15 AUD
-0.02 AUD
-0.02 AUD
Jan 1, 2025
0.15 AUD
-0.01 AUD
-0.01 AUD

Global Health business model & stock analysis

Global Health Ltd is a British company that has been operating in the healthcare industry since 2004. Its foundation was a response to the increasing demand for better access to healthcare in developing countries. The company has continuously expanded and improved its business model to meet the changing demands of the healthcare industry. An important aspect of Global Health Ltd's business model is its collaboration with governments and non-governmental organizations (NGOs). The company provides comprehensive consultation services to assist governments in planning, developing, and implementing healthcare programs. This includes improving vaccination programs, strengthening healthcare systems, and developing strategies to reduce diseases. Through partnerships with NGOs, Global Health Ltd also enables access to healthcare services in rural and remote areas. The company also provides services in the field of medical research and development, working closely with academic institutions, non-profit organizations, and pharmaceutical companies to promote the development of new drugs and vaccines and support clinical research. Global Health Ltd offers specialized divisions focused on specific areas of the healthcare industry. For example, the company provides medical devices and equipment, including mobile healthcare solutions, to meet the increasing importance of digital technology in healthcare. Additionally, Global Health Ltd is involved in training and education for medical professionals, including training programs for healthcare personnel in developing countries and training for pharmaceutical companies and clinical research institutions. Another important division of the company is its healthcare services, operating healthcare centers in various countries, including clinics that offer specialized services such as ophthalmology, gynecology, and obstetrics. These healthcare centers aim to provide high-quality healthcare at affordable costs and serve as important sources of healthcare and prevention in many regions. Global Health Ltd also offers nutritional supplements specifically tailored to the needs of children and pregnant women. These products are developed and manufactured in collaboration with health authorities and NGOs in developing countries to combat malnutrition and deficiencies. Through its diverse offerings and collaborations with governments, NGOs, and other stakeholders, Global Health Ltd is committed to improving access to healthcare worldwide. The company strives to enable sustainable and affordable healthcare for all, making an important contribution to the global health agenda.

Global Health SWOT Analysis

Strengths

Global Health Ltd has established a strong market presence in the healthcare industry, with a wide range of products and services.

The company boasts a strong financial position, enabling it to invest in research and development, expand its operations, and withstand economic fluctuations.

Global Health Ltd offers a diverse product line, catering to various healthcare segments and addressing different customer needs, allowing for higher market share and revenue potential.

Weaknesses

Global Health Ltd currently has limited international presence, which may restrain its growth opportunities in emerging markets and expose it to regional market fluctuations.

The company relies heavily on a few key suppliers for its raw materials, which presents a vulnerability to disruptions in the supply chain and potential price fluctuations.

Global Health Ltd faces limitations in fully integrating advanced technologies into its operations, which may hinder its ability to optimize processes and stay competitive in the fast-paced healthcare industry.

Opportunities

The increasing aging population presents a significant opportunity for Global Health Ltd to expand its products and services targeting elderly individuals, such as specialized healthcare solutions and assistive devices.

Rapid advancements in technology open doors for Global Health Ltd to innovate in areas like telemedicine, healthcare analytics, and digital health solutions, enhancing patient care and improving operational efficiency.

Global Health Ltd can leverage the growth potential in emerging markets by expanding its presence, forming strategic partnerships, and customizing products to meet specific market needs, thereby increasing its global market share.

Threats

The healthcare industry is highly competitive, with numerous players competing for market share. Global Health Ltd faces the threat of new entrants, competitive pricing, and continuous innovation from existing competitors.

Compliance with complex regulations and evolving healthcare policies can pose challenges for Global Health Ltd, requiring constant adaptation to changes in legal frameworks and maintaining strict quality standards.

Economic downturns, fluctuations in currency exchange rates, and rising costs of raw materials could impact Global Health Ltd's profitability, making it essential to have robust risk management strategies in place.

Global Health Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Global Health historical P/E ratio, EBIT multiple, and P/S ratio

Global Health annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Global Health shares outstanding

The number of shares of Global Health was 58.21 M in 2025. This indicates how many shares Global Health is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2018
35.70 M Stocks
Jan 1, 2019
35.81 M Stocks
Jan 1, 2020
39.04 M Stocks
Jan 1, 2021
42.36 M Stocks
Jan 1, 2022
56.00 M Stocks
Jan 1, 2023
57.52 M Stocks
Jan 1, 2024
58.05 M Stocks
Jan 1, 2025
58.21 M Stocks

Global Health stock splits

In Global Health's history, there have been no stock splits.

Global Health Dividend History

2 years of dividend payments

YearAnnual DividendYoY ChangePayments
20170.01AUD 0.0%1×
20160.01AUD—1×

Global Health dividend payout ratio

In 2025, Global Health had a payout ratio of 142.16%. The payout ratio indicates the percentage of the company's profits that Global Health distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2018
166.39 %
Jan 1, 2019
166.39 %
Jan 1, 2020
117.73 %
Jan 1, 2021
150.17 %
Jan 1, 2022
144.77 %
Jan 1, 2023
137.56 %
Jan 1, 2024
144.16 %
Jan 1, 2025
142.16 %
Price targets and forecasts for Global Health are not yet available.

Global Health shareholder structure

% Name
41.53609%
Cherian (Alumootil Mathew )
Cherian (Alumootil Mathew )
13.83699%
HD Capital Partners Pty. Ltd.
HD Capital Partners Pty. Ltd.
3.48372%
Mclaren (Paul)
Mclaren (Paul)
2.96940%
Thomas (Elizabeth May Priscilla)
Thomas (Elizabeth May Priscilla)
2.43599%
Connaught Consultants (Finance) Pty. Ltd.
Connaught Consultants (Finance) Pty. Ltd.
2.39665%
Lim (Serene)
Lim (Serene)

Global Health Executives and Management Board

MC

Mr. Mathew Cherian

Managing Director, Executive Director · since 2021

Compensation394,876.00 AUD
MD

Mr. Michael Davies

Chief Executive Officer

Compensation354,962.00 AUD
KC

Mr. Kye Cherian

Manager, Product Portfolio

Compensation241,056.00 AUD
DG

Mr. Damon Groenveld

Principal Architect

Compensation227,645.00 AUD
AP

Atty. Steven Pynt

Independent Non-Executive Chairman of the Board · since 2017

Compensation69,326.00 AUD

Frequently asked questions about Global Health

The business model of Global Health Ltd revolves around providing innovative healthcare solutions and services. They aim to improve the efficiency and effectiveness of healthcare delivery by offering software products and technology solutions to healthcare providers, hospitals, and clinics. Global Health Ltd focuses on developing and delivering integrated clinical and administrative solutions, electronic medical records (EMR), and patient management systems. Their comprehensive suite of products and services helps streamline workflow processes, enhance communication, and optimize patient care. By leveraging advanced technology, Global Health Ltd is committed to transforming the healthcare industry and empowering healthcare professionals worldwide.

All fundamentals and in-depth analysis of Global Health

Our stock analysis for Global Health stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Global Health. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Global Health Stock
Global Health Revenue→
Global Health Stock
Global Health Net Income→
Global Health Stock
Global Health P/E→
Global Health Stock
Global Health P/S→
Global Health Stock
Global Health EBIT→
Global Health Stock
Global Health Dividend→
Global Health Stock
Global Health Directors Dealings→
Global Health Stock
Global Health Stocks→
Global Health Stock
Global Health Market capitalization→
Global Health Stock
Global Health Debt→
Global Health Stock
Global Health Liabilities→
Global Health Stock
Global Health Equity→
Global Health Stock
Global Health AAQS→
Global Health Stock
Global Health Employees→
Global Health Stock
Global Health ROE→
Global Health Stock
Global Health ROA→
Global Health Stock
Global Health ROCE→
Global Health Stock
Global Health News→
Global Health Stock
Global Health Analyst Price Targets→

Health Stocks

Global Health ClinicsGlobal HealthGlobal Longlife Hospital and ResearchGlobal Cord BloodGlobaltech HoldingsGlenmark PharmaceuticalsGlobeimmuneGlaxoSmithKline SAEGlobeStar TherapeuticsGlaxoSmithKline PLC ADRGlobus MedicalGlaxoSmithKline PharmaceuticalsAll Stocks A–Z →